(19)
(11) EP 2 222 631 A2

(12)

(88) Date of publication A3:
17.06.2010

(43) Date of publication:
01.09.2010 Bulletin 2010/35

(21) Application number: 07825406.7

(22) Date of filing: 11.10.2007
(51) International Patent Classification (IPC): 
C07C 233/73(2006.01)
C07D 215/04(2006.01)
A61K 31/473(2006.01)
C07D 215/48(2006.01)
A61P 29/00(2006.01)
A61K 31/166(2006.01)
(86) International application number:
PCT/IB2007/003106
(87) International publication number:
WO 2008/050199 (02.05.2008 Gazette 2008/18)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 23.10.2006 US 862485 P

(71) Applicant: Pfizer Inc.
New York, NY 10017 (US)

(72) Inventors:
  • ANDO, Koji
    Chita-gun Aichi-ken 470-2393 (JP)
  • TANAKA, Hirotaka
    Chita-gun Aichi-ken 470-2393 (JP)

(74) Representative: Hodge, Emma Jane 
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) SUBSTITUTED PHENYLMETHYL BICYCLOCARBOXYAMIDE COMPOUNDS